The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy

被引:10
|
作者
Erickson, Beth A. [1 ]
Bittner, Nathan H. J. [2 ]
Chadha, Manjeet [3 ]
Mourtada, Firas [4 ,5 ]
Demanes, D. Jeffrey [6 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Tacoma Valley Radiat Oncol Ctr, Tacoma, WA USA
[3] Mt Sinai Beth Israel, New York, NY USA
[4] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE USA
[5] Christiana Care Hlth Syst, Res Inst, Newark, DE USA
[6] UCLA Hlth Syst, Los Angeles, CA USA
关键词
High-dose-rate brachytherapy; HDR brachytherapy; Radionuclides; Radiation therapy; Radioactive sources; Oncologic practice; Radiation oncologist; SQUAMOUS-CELL CARCINOMA; INTRAOPERATIVE RADIATION-THERAPY; RATE INTRACAVITARY THERAPY; RECURRENT PROSTATE-CANCER; SOFT-TISSUE SARCOMAS; ORAL TONGUE CANCER; INTERSTITIAL BRACHYTHERAPY; HDR BRACHYTHERAPY; CONSENSUS GUIDELINES; RANDOMIZED-TRIAL;
D O I
10.1016/j.brachy.2016.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Brachytherapy is a radiation therapy method in which radionuclide sources are used to deliver a radiation dose at a distance of up to a few centimeters by surface, intracavitary, intraluminal, or interstitial application. This practice parameter refers only to the use of radionuclides for brachytherapy. Brachytherapy alone or combined with external beam therapy plays an important role in the management and treatment of patients with cancer. High-dose-rate (HDR) brachytherapy uses radionuclides such as iridium-192 at dose rates of 20 cGy per minute (12 Gy per hour) or more to a designated target point or volume. High-dose-rate (HDR) brachytherapy is indicated for treating malignant or benign tumors where the treatment volume or targeted points are defined and accessible. (C) 2016 American Brachytherapy Society and American College of Radiology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 50 条
  • [11] High-dose-rate brachytherapy and pulsed brachytherapy
    Mazeron, JJ
    [J]. EUROCANCER 2002, 2002, : 57 - 58
  • [12] American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy
    Viswanathan, Akila N.
    Beriwal, Sushil
    De Los Santos, Jennifer F.
    Demanes, D. Jeffrey
    Gaffney, David
    Hansen, Jorgen
    Jones, Ellen
    Kirisits, Christian
    Thomadsen, Bruce
    Erickson, Beth
    [J]. BRACHYTHERAPY, 2012, 11 (01) : 47 - 52
  • [13] Dosimetric evaluation of tandem-based cervical high-dose-rate brachytherapy treatment planning using American Brachytherapy Society 2011 recommendations
    Goyal, Manish K.
    Kehwar, T. S.
    Manjhi, Jayanand
    Barker, Jerry L.
    Heintz, Bret H.
    Shide, Kathleen L.
    Rai, D. V.
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2016, 15 (03) : 283 - 289
  • [14] HIGH-DOSE-RATE BRACHYTHERAPY
    SPEISER, BL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 116 - 116
  • [15] The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries
    Grover, Surbhi
    Lichter, Katie E.
    Likhacheva, Anna
    Jang, Joanne W.
    Ning, Matthew S.
    Robin, Tyler P.
    Small, William, Jr.
    Kudchadker, Rajat J.
    Swamidas, Jamema
    Chopra, Supriya
    Rai, Bhavana
    Sharma, Sunil Dutt
    Sharma, Daya N.
    Kuppusamy, Thayalan
    Yang, Ruijie
    Berger, Daniel
    Mendez, Lisbeth Cordero
    Glaser, Scott
    Erickson, Delnora L.
    Chino, Junzo
    Mourtada, Firas
    Abdel-Wahab, May
    Jhingran, Anuja
    Simonds, Hannah
    Mahantshetty, Umesh
    [J]. BRACHYTHERAPY, 2023, 22 (06) : 716 - 727
  • [16] The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix
    Nag, S
    Chao, C
    Erickson, B
    Fowler, J
    Gupta, N
    Martinez, A
    Thomadsen, B
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01): : 33 - 48
  • [17] American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer
    Mayadev, Jyoti
    Viswanathan, Akila
    Liu, Yu
    Li, Chin-Shang
    Albuquerque, Kevin
    Damato, Antonio L.
    Beriwal, Sushil
    Erickson, Beth
    [J]. BRACHYTHERAPY, 2017, 16 (01) : 22 - 43
  • [18] AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) AND AMERICAN COLLEGE OF RADIOLOGY (ACR) PRACTICE GUIDELINE FOR THE TRANSPERINEAL PERMANENT BRACHYTHERAPY OF PROSTATE CANCER
    Rosenthal, Seth A.
    Bittner, Nathan H. J.
    Beyer, David C.
    Demanes, D. Jeffrey
    Goldsmith, Brian J.
    Horwitz, Eric M.
    Ibbott, Geoffrey S.
    Lee, W. Robert
    Nag, Subir
    Suh, W. Warren
    Potters, Louis
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 335 - 341
  • [19] Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer
    Pos, FJ
    Horenblas, S
    Lebesque, J
    Moonen, L
    Schneider, C
    Sminia, P
    Bartelink, H
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 696 - 705
  • [20] Modern development of high-dose-rate brachytherapy
    Itami, Jun
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (05) : 490 - 501